Whereas S100A8 (log2FC: 5.5) and S100A9 (log2FC: 4.6) were up-regulated in active IBD, both transcripts returned to expression levels of non-IBD controls in EH. This evidence concerns the gene S100A9 and inflammatory bowel disease.